These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

153 related items for PubMed ID: 3904387

  • 1. Electropharmacologic testing in sustained ventricular tachycardia associated with coronary heart disease: value of the response to intravenous procainamide in predicting the response to oral procainamide and oral quinidine treatment.
    Oseran DS, Gang ES, Rosenthal ME, Mandel WJ, Peter T.
    Am J Cardiol; 1985 Nov 15; 56(13):883-6. PubMed ID: 3904387
    [Abstract] [Full Text] [Related]

  • 2. Usefulness of the response to intravenous procainamide during electrophysiologic study in predicting the response to oral quinidine in patients with inducible sustained monomorphic ventricular tachycardia associated with coronary artery disease.
    Pires LA, Wagshal AB, Greene TO, Mittleman RS, Huang SK.
    Am J Cardiol; 1993 Oct 15; 72(12):908-10. PubMed ID: 8105674
    [Abstract] [Full Text] [Related]

  • 3. Recurrent sustained ventricular tachycardia 3. Role of the electrophysiologic study in selection of antiarrhythmic regimens.
    Horowitz LN, Josephson ME, Farshidi A, Spielman SR, Michelson EL, Greenspan AM.
    Circulation; 1978 Dec 15; 58(6):986-97. PubMed ID: 709782
    [Abstract] [Full Text] [Related]

  • 4. The role of combination therapy with mexiletine and procainamide in patients with inducible sustained ventricular tachycardia refractory to intravenous procainamide.
    Widerhorn J, Sager PT, Rahimtoola SH, Bhandari AK.
    Pacing Clin Electrophysiol; 1991 Mar 15; 14(3):420-6. PubMed ID: 1708872
    [Abstract] [Full Text] [Related]

  • 5. Paired comparisons of efficacy of intravenous and oral procainamide in patients with inducible sustained ventricular tachyarrhythmias.
    Interian A, Zaman L, Velez-Robinson E, Kozlovskis P, Castellanos A, Myerburg RJ.
    J Am Coll Cardiol; 1991 Jun 15; 17(7):1581-6. PubMed ID: 2033190
    [Abstract] [Full Text] [Related]

  • 6. Usefulness of the electrophysiology laboratory for evaluation of proarrhythmic drug response in coronary artery disease.
    Buxton AE, Rosenthal ME, Marchlinski FE, Miller JM, Flores B, Josephson ME.
    Am J Cardiol; 1991 Apr 15; 67(9):835-42. PubMed ID: 1707220
    [Abstract] [Full Text] [Related]

  • 7. Comparative electrophysiologic effects of intravenous and oral procainamide in patients with sustained ventricular arrhythmias.
    Marchlinski FE, Buxton AE, Vassallo JA, Waxman HL, Cassidy DM, Doherty JU, Josephson ME.
    J Am Coll Cardiol; 1984 Dec 15; 4(6):1247-54. PubMed ID: 6209319
    [Abstract] [Full Text] [Related]

  • 8. The role of beta-blockade therapy for ventricular tachycardia induced with isoproterenol: a prospective analysis.
    DiCarlo LA, Susser F, Winston SA.
    Am Heart J; 1990 Dec 15; 120(6 Pt 1):1347-55. PubMed ID: 1978977
    [Abstract] [Full Text] [Related]

  • 9. Electropharmacologic effect of a standard dose of intravenous procainamide in patients with sustained ventricular tachycardia.
    Rials SJ, Britchkow D, Marinchak RA, Kowey PR.
    Clin Cardiol; 2000 Mar 15; 23(3):171-4. PubMed ID: 10761804
    [Abstract] [Full Text] [Related]

  • 10. Electrophysiologic evaluation of the antiarrhythmic effects of N-acetylprocainamide for ventricular tachycardia secondary to coronary artery disease.
    Wynn J, Miura DS, Torres V, Flowers D, Keefe D, Williams S, Somberg JC.
    Am J Cardiol; 1985 Nov 15; 56(13):877-81. PubMed ID: 2414983
    [Abstract] [Full Text] [Related]

  • 11. Electrophysiologic and clinical factors influencing response to class IA antiarrhythmic agents in patients with inducible sustained monomorphic ventricular tachycardia.
    Gold RL, Haffajee CI, Alpert JS.
    Am Heart J; 1986 Jul 15; 112(1):9-13. PubMed ID: 3728294
    [Abstract] [Full Text] [Related]

  • 12. Enhanced efficacy of oral sotalol for sustained ventricular tachycardia refractory to type I antiarrhythmic drugs.
    Kienzle MG, Martins JB, Wendt DJ, Constantin L, Hopson R, McCue ML.
    Am J Cardiol; 1988 May 01; 61(13):1012-7. PubMed ID: 3129926
    [Abstract] [Full Text] [Related]

  • 13. Amiodarone versus amiodarone and a type IA agent for treatment of patients with rapid ventricular tachycardia.
    Marchlinski FE, Buxton AE, Miller JM, Vassallo JA, Flores BT, Josephson ME.
    Circulation; 1986 Nov 01; 74(5):1037-43. PubMed ID: 3769163
    [Abstract] [Full Text] [Related]

  • 14. Limitations of failure of procainamide during electrophysiologic testing to predict response to other medical therapy.
    Rae AP, Sokoloff NM, Webb CR, Spielman SR, Greenspan AM, Horowitz LN.
    J Am Coll Cardiol; 1985 Aug 01; 6(2):410-6. PubMed ID: 4019928
    [Abstract] [Full Text] [Related]

  • 15. Effects of intravenous disopyramide and quinidine on normal myocardium and on the characteristics of arrhythmias: intraindividual comparison in patients with sustained ventricular tachycardia.
    Rizos I, Brachmann J, Lengfelder W, Schmitt C, von Olshausen K, Kübler W, Senges J.
    Eur Heart J; 1987 Feb 01; 8(2):154-63. PubMed ID: 3569310
    [Abstract] [Full Text] [Related]

  • 16. Effects of incremental doses of procainamide on ventricular refractoriness, intraventricular conduction, and induction of ventricular tachycardia.
    Morady F, DiCarlo LA, de Buitleir M, Krol RB, Baerman JM, Kou WH.
    Circulation; 1986 Dec 01; 74(6):1355-64. PubMed ID: 2430731
    [Abstract] [Full Text] [Related]

  • 17. Efficacy of combination therapy with mexiletine and a type IA agent for inducible ventricular tachyarrhythmias secondary to coronary artery disease.
    Greenspan AM, Spielman SR, Webb CR, Sokoloff NM, Rae AP, Horowitz LN.
    Am J Cardiol; 1985 Aug 01; 56(4):277-84. PubMed ID: 4025166
    [Abstract] [Full Text] [Related]

  • 18. Intravenous quinidine: relations among concentration, tachyarrhythmia suppression and electrophysiologic actions with inducible sustained ventricular tachycardia.
    Duff HJ, Wyse DG, Manyari D, Mitchell LB.
    Am J Cardiol; 1985 Jan 01; 55(1):92-7. PubMed ID: 3966404
    [Abstract] [Full Text] [Related]

  • 19. Prospective comparison of intravenous quinidine and intravenous procainamide in patients undergoing electrophysiologic testing.
    Holzberger PT, Greenberg ML, Paicopolis MC, Ozahowski TP, Ho PC, O'Connor GT.
    Am Heart J; 1998 Jul 01; 136(1):49-56. PubMed ID: 9665218
    [Abstract] [Full Text] [Related]

  • 20. Coronary venous retroinfusion of procainamide: a new approach for the management of spontaneous and inducible sustained ventricular tachycardia during myocardial infarction.
    Karagueuzian HS, Ohta M, Drury JK, Fishbein MC, Meerbaum S, Corday E, Mandel WJ, Peter T.
    J Am Coll Cardiol; 1986 Mar 01; 7(3):551-63. PubMed ID: 3950235
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.